The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 106.00
Bid: 105.00
Ask: 106.00
Change: 0.50 (0.47%)
Spread: 1.00 (0.952%)
Open: 106.00
High: 106.50
Low: 105.00
Prev. Close: 105.50
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cash Offer Launch

2 Nov 2023 13:29

RNS Number : 2343S
International Personal Finance Plc
02 November 2023

Publication of final terms and launch of 12 per cent. Sterling notes due 2027

The information contained herein may only be released, published or distributed in the United Kingdom, the Isle of Man, Jersey and the Bailiwick of Guernsey in accordance with applicable regulatory requirements. The information contained herein is not for release, publication or distribution in or into the United States, Australia, Canada, Japan, South Africa, the Republic of Ireland or in any other jurisdiction where it is unlawful to distribute this announcement.

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED.

SEE "IMPORTANT INFORMATION" BELOW

2 November 2023

International Personal Finance plcLAUNCH OF OFFER OF 12 PER CENT. STERLING-DENOMINATED NOTES DUE 2027

International Personal Finance PLC (the "Issuer" or "IPF"), the holding company for a global consumer finance helping people excluded from mainstream finance to access simple, personal and affordable credit, has today launched an offer of senior unsecured 12 per cent. Sterling-denominated notes due 2027 (the "New Notes") (to be consolidated and form a single series with the £50,000,000 12 per cent. Notes due 2027 issued on 12 December 2022). The New Notes are available to retail investors in the United Kingdom and are being issued by IPF at an issue price of 100 per cent. of their aggregate nominal amount, for general corporate purposes.

At the same time, the Issuer is announcing an invitation (the "Exchange Offer") to holders of its existing Sterling-denominated 7.75 per cent. notes due 2023 (ISIN: XS1998163148) (the "2023 Notes") to exchange their 2023 Notes for new, retail eligible, senior unsecured 12 per cent. Sterling-denominated notes due 12 December 2027. Any notes issued pursuant to the Exchange Offer will form a single series with the New Notes on settlement on 12 December 2023.

The New Notes will bear interest at a fixed rate of 12 per cent. per annum, payable semi-annually in arrear on 12 June and 12 December, each year and will be redeemed (subject to and in accordance with their terms and conditions) at their nominal value on 12 December 2027. Holders of New Notes should, in most normal circumstances, be able to sell their holdings during normal trading hours (subject to market conditions) on the open market through their stockbroker.

The New Notes are expected to be rated BB- by Fitch and Ba3 by Moody's Investors Service.

The New Notes have a minimum initial subscription amount of £2,000 and are available in multiples of £100 thereafter.

The offer period is now open and is expected to close at 12:00 noon (London time) on 23 November 2023. Singer Capital Markets Securities Limited, acting as the Dealer Manager, retains the right to close the offer early, in conjunction with IPF.

The New Notes are expected to be listed on the Financial Conduct Authority's Official List and admitted to trading on the electronic order book for retail bonds of the London Stock Exchange plc's Main Market.

The Final Terms for the New Notes can be found here https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

- ENDS -

For further information, please contact:

International Personal Finance plc

Georgia Dunn (Deputy Company Secretary)

+44 (0)113 539 5466

Kris Adamski (Group Treasurer)

+44 (0)113 539 5466

IMPORTANT INFORMATION

This announcement is released by International Personal Finance PLC and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of Regulation (EU) 596/2014 as it forms part of UK domestic law pursuant to the European Union (Withdrawal) Act 2018, as amended ("EUWA") ("UK MAR"), encompassing information relating to an exchange offer, as described above. For the purposes of UK MAR, this announcement is made by Tom Crane for International Personal Finance plc.

The distribution of this announcement and other information in connection with any offer of securities and/or the solicitation of offers for securities in certain jurisdictions may be restricted by law and persons who come into possession of this announcement or any document or other information referred to herein should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any jurisdiction.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any securities. This announcement does not constitute and shall not, in any circumstances, constitute a public offering nor an invitation to the public in connection with any offer within the meaning of Regulation (EU) 2017/1129 (the "EU Prospectus Regulation") as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended (the "UK Prospectus Regulation"). Any offer and sale of any securities will be made in compliance with the requirements of the UK Prospectus Regulation.

Any securities referred to herein will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"). Subject to certain exceptions, such securities may not be offered, sold or delivered within the United States. The Exchange New Notes (as defined in the Exchange Offer Memorandum), which are in bearer form, are subject to U.S. tax law requirements. Any securities referred to herein would be offered and sold outside of the United States in reliance on Regulation S of the Securities Act. There will be no public offering in the United States.

This announcement does not constitute and shall not, in any circumstances, constitute a public offering nor an invitation to the public in connection with any offer within the meaning of the UK Prospectus Regulation. Any offer and sale of any securities will be made in compliance with the requirements of the UK Prospectus Regulation.

A credit rating is not a recommendation to buy, sell or hold any securities, and may be reduced or withdrawn by the assigning rating agency at any time.

Legal Entity Identifier: 213800II1O44IRKUZB5

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCXLLFBXFLLFBD
Date   Source Headline
8th Apr 20241:13 pmRNSDirector/PDMR Shareholding
5th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 202410:48 amRNSDirector/PDMR Shareholding
3rd Apr 20243:29 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20245:09 pmRNSDirector/PDMR Shareholding
25th Mar 20244:44 pmRNSAnnual Financial Report and Notice of AGM
21st Mar 20245:09 pmRNSDirector/PDMR Shareholding
19th Mar 20243:56 pmRNSDirector/PDMR Shareholding
18th Mar 20244:11 pmRNSDirector/PDMR Shareholding
15th Mar 202410:38 amRNSFinal Dividend Timetable Correction
14th Mar 20247:00 amRNSFinal Results and Accounts
26th Feb 20247:00 amRNSDelay of year-end results announcement
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Dec 20239:08 amRNSHolding(s) in Company
14th Dec 202311:24 amRNSPublication of Final Terms
24th Nov 20237:02 amRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSFinal Confirmation & Results of Exchange Offer
17th Nov 20233:18 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSAppointment of Joint Broker
14th Nov 20233:09 pmRNSHolding(s) in Company
8th Nov 20237:00 amRNSNotice of Investor Webinar - 7 December 2023
3rd Nov 20234:14 pmRNSIssuance and amendment to Final Terms
2nd Nov 20231:29 pmRNSCash Offer Launch
2nd Nov 20231:18 pmRNSExchange Offer
2nd Nov 20231:16 pmRNSPublication of a Prospectus
26th Oct 20237:01 amRNSRoadshow Announcement
26th Oct 20237:00 amRNSQ3 2023 Trading Update
25th Oct 20232:12 pmRNSChange of Senior Independent Director
24th Oct 20233:19 pmRNSPublication of Final Terms - Replacement Notice
24th Oct 20237:00 amRNSPublication of Final Terms
20th Oct 20237:00 amRNSUpdate on Annual General Meeting 2023 Vote
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20231:46 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSTotal Voting Rights
24th Aug 20234:35 pmRNSPublication of a Prospectus
1st Aug 20237:00 amRNSHalf-year Report
13th Jul 202311:14 amRNSHolding(s) in Company
3rd Jul 20232:30 pmRNSTotal Voting Rights
3rd Jul 20239:20 amRNSBlock listing Interim Review
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20234:48 pmRNSDirector/PDMR Shareholding
4th May 202311:17 amRNSDirector/PDMR Shareholding
2nd May 202312:28 pmRNSTotal Voting Rights
27th Apr 20234:27 pmRNSResult of AGM
27th Apr 20237:00 amRNSQ1 2023 Trading Update
19th Apr 20234:44 pmRNSNotice of Investor Briefing - 10 May 2023
6th Apr 20232:54 pmRNSDirector/PDMR Shareholding
4th Apr 20234:42 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:37 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.